From: Phase II study of helical tomotherapy in the multidisciplinary treatment of oligometastatic colorectal cancer
No. of patients
%
Complete metabolic response
6
27.3
Partial metabolic response
Stable metabolic disease
3
13.6
Progressive metabolic disease
7
31.8
No PET
2